Menu

#SellAs

1 post

Feed
1 of 1 post
0Read More

SELLAS Life Sciences Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Business - Latest - Google News·3 days ago
#yXvIcVhQ
#world#news#ir#million#sellas

- Topline Primary Endpoint Results of the Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia Following the 80th Event to Report this Month - - 40 Patients Enrolled in Phase 2 Trial of SLS009 in Newly Diagnosed First-Line AML;…

15s